Tumor stroma proportion to predict platinum chemoresistance in primary ovarian carcinomas: A prospective study.

5581Background: Platinum chemotherapy resistance occurs in approximately 25% of patients with ovarian carcinoma and represents a major barrier to effective care of this patient population. To date ...